ELEKTA B SHS ADR Stock News

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Elekta AB (OTCPK:EKTAF) Q2 2024 Earnings Conference Call November 30, 2023 4:00 AM ET Company Participants Cecilia Ketels - Head, IR Gustaf Salford - President & CEO Tobias Hagglov - CFO Conference Ca

Elekta AB (publ) (OTCPK:EKTAF) Q3 2023 Earnings Conference Call February 24, 2023 4:00 AM ET Company Participants Cecilia Ketels - Head of Investor Relations Gustaf Salford - President & Chief Executi

Elekta AB (publ) (OTCPK:EKTAF) Q2 2023 Results Conference Call November 24, 2022 12:00 PM ET Company Participants Cecilia Ketels - Head of IR Gustaf Salford - President & CEO Tobias Hagglov - CFO Conf

Elekta AB (publ) (OTCPK:EKTAF) Q1 2023 Earnings Conference Call August 25, 2022 4:00 AM ET Company Participants Cecilia Ketels - Head of IR Gustaf Salford - President & CEO Tobias Hagglov - CFO Confer

Elekta AB (publ) (OTCPK:EKTAF) Q4 2022 Earnings Conference Call May 25, 2022 4:00 AM ET Company Participants Cecilia Ketels - Head of Investor Relations Gustaf Salford - President and Chief Executive

Elekta AB (publ) Q3 2022 Earnings Conference Call February 24, 2022 4:00 AM ET

New York, Dec. 17, 2021 (GLOBE NEWSWIRE) -- According to the new market research report " Radiotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiotherapy/Radiopharmaceuticals), Product (External Beam Radiotherapy Products, Internal Radiotherapy Products, Radiotherapy Software, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), and End User (Hospitals, Radiation Therapy Centers, and Specialty Clinics), and Geography", published by The Insight Partners , the global radiotherapy market was valued at US$ 6,474.78 million in 2020 and it is projected to reach US$ 10,170.80 million by 2028; it is expected to grow at a CAGR of 5.9% from 2021 to 2028. Get Exclusive Sample Pages of Radiotherapy Market Size - COVID-19 Impact and Global Analysis with Strategic Insights: https://www.theinsightpartners.com/sample/TIPMD00002668/ Radiotherapy Market: Competition Landscape and Key Developments Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries, Ltd., Elekta AB, Hitachi, Ltd., Koninklijke Philips N.V., Brainlab AG, PROTOM INTERNATIONAL, Varian Medical Systems, Inc., Maastro, and Mevion Medical Systems are among the key companies operating in the radiotherapy market.